| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/03/2011 | CN101606985B Liniment for treating sheep infective pustule virus and preparation method thereof |
| 08/03/2011 | CN101550181B Human papilloma virus 16 type E7 protein functional antagonist peptide and encoding gene and application thereof |
| 08/03/2011 | CN101548983B Skin disinfectant and method of producing the same |
| 08/03/2011 | CN101525378B Listonella anguillarum subunit vaccine antigenic protein and application thereof |
| 08/03/2011 | CN101380316B Multifunctional external antibiotic preparation and production method thereof |
| 08/03/2011 | CN101379066B HCV NS5B inhibitors |
| 08/03/2011 | CN101311190B Antigen epitope for exciting protective immunity against tubercle bacillus of human body and uses thereof |
| 08/03/2011 | CN101213198B 1-[2',3'-dideoxy-3'C-(hydroxymethyl)-beta-D-erythro-pentofuranosyl] cytosine derivatives as HIV inhibitors |
| 08/03/2011 | CN101143861B B ring 4'-single substituted flavone compounds, preparation method and use |
| 08/03/2011 | CN101129904B Chest-clearing tuberculosis-dispelling pill for treating tuberculous pleurisy, peritonitis, empyema and bronchopleural fistula |
| 08/02/2011 | US7989605 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 08/02/2011 | US7989491 Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections |
| 08/02/2011 | US7989459 Purinones and 1H-imidazopyridinones as PKC-theta inhibitors |
| 08/02/2011 | US7989438 Therapeutic compounds |
| 08/02/2011 | US7989432 Micelles |
| 08/02/2011 | US7989423 6″-amino-6″-deoxygalactosylceramides |
| 08/02/2011 | US7989203 Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells |
| 08/02/2011 | US7989004 Antitubercular extracts of Salicornia brachiata |
| 08/02/2011 | US7988979 Neisseria meningitidis antigens and compositions |
| 08/02/2011 | US7988974 comprise a macromolecular carrier group fused to a gp41-derived DP178 peptide corresponding to amino acids 638 to 673 of the HIV-1LA1 gp41 protein; inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells |
| 08/02/2011 | US7988956 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 08/02/2011 | US7988952 Condensation aerosol formed by heating a thin layer containing the ester, on a solid support to produce a vapor of the ester, and condensing; less than 10% ester degradation products by weight, and a Mass median aerodynamic diameter of less than 5 microns |
| 08/02/2011 | CA2655485C Penem prodrugs |
| 08/02/2011 | CA2496538C Boronic ester and acid compounds, synthesis and uses |
| 08/02/2011 | CA2486678C Non-viral gene delivery system |
| 08/02/2011 | CA2479109C Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 08/02/2011 | CA2474043C Heterocyclic compounds which are active as inhibitors of beta lactamases |
| 08/02/2011 | CA2457218C Process for purifying glycopeptide phosphonate derivatives |
| 08/02/2011 | CA2447632C Fusion protein agonist comprising a growth hormone binding portion and an external domain of a growth hormone receptor |
| 08/02/2011 | CA2442870C Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors |
| 08/02/2011 | CA2442682C Monocyte-specific particulate delivery vehicle |
| 08/02/2011 | CA2441690C Method for the identification of antigenic peptides |
| 08/02/2011 | CA2434063C Substituted quinolines for the treatment of protozoan and retrovirus co-infections |
| 08/02/2011 | CA2405349C Oxazolidinone derivatives with antibiotic activity |
| 08/02/2011 | CA2323207C Food products having enhanced cocoa polyphenol content and processes for producing same |
| 08/02/2011 | CA2265498C Staphylococcus aureus antigen |
| 07/28/2011 | WO2011091376A2 Immunogenic influenza composition |
| 07/28/2011 | WO2011091319A2 Dendritic cell vaccines |
| 07/28/2011 | WO2011091027A2 Recombinant live attenuated foot-and-mouth disease (fmd) vaccine containing mutations in the l protein coding region |
| 07/28/2011 | WO2011090885A2 Enhanced anti-microbial pdt |
| 07/28/2011 | WO2011090712A2 Methods for stabilizing influenza antigen enveloped virus-based virus-like particle solutions |
| 07/28/2011 | WO2011090345A2 Novel antibiotic composition comprising flufenamic acid as an active ingredient |
| 07/28/2011 | WO2011090307A2 Sirna having antiviral activity against both enterovirus 70 and coxsackievirus a24, and pharmaceutical composition for treating and preventing acute hemorrhagic conjunctivitis containing same |
| 07/28/2011 | WO2011090095A1 Heterocyclic compound having azole group |
| 07/28/2011 | WO2011089561A1 Methods for producing amino-substituted glycolipid compounds |
| 07/28/2011 | WO2011089457A1 Novel medicinal compounds |
| 07/28/2011 | WO2011089456A1 Novel medicinal compounds |
| 07/28/2011 | WO2011089167A1 Kombination of proteasome inhibitors and anti -hepatitis medication for treating retroviral diseases |
| 07/28/2011 | WO2011089166A1 Semicarbazone proteasome inhibitors for treating hiv and hepatitis infection |
| 07/28/2011 | WO2011088745A1 Ophthalmic external antibacterial medicine |
| 07/28/2011 | WO2011088688A1 Polymer micelle medicine carrier comprising amino acid as stabilizer |
| 07/28/2011 | WO2011088561A1 Anti-viral compounds and compositions |
| 07/28/2011 | WO2011088549A1 Derivatives of pyridoxine for inhibiting hiv integrase |
| 07/28/2011 | WO2011088532A1 Pharmaceutical compositions for the treatment of bacterial infections |
| 07/28/2011 | US20110184379 Method and system to define patient specific therapeutic regimens by means of pharmacokinetic and pharmacodynamic tools |
| 07/28/2011 | US20110184145 Method of administering therapeutic polypeptides, and polypeptides therefor |
| 07/28/2011 | US20110184070 Novel compounds, use thereof as medicaments, and method of preparation thereof |
| 07/28/2011 | US20110184069 Methods and compositions for administration of trpv1 agonists |
| 07/28/2011 | US20110184064 Therapeutic agent for hepatitis c |
| 07/28/2011 | US20110184051 Pharmacological applications of mitochondrial dna assays |
| 07/28/2011 | US20110184034 Severe sepsis preventive therapeutic agent |
| 07/28/2011 | US20110184028 Derivatives of pyridoxine for inhibiting hiv integrase |
| 07/28/2011 | US20110184026 C4-substituted alpha-keto oxazoles |
| 07/28/2011 | US20110184025 Methods and Compositions Using Immunomodulatory Compounds for the Treatment and Management of Spirochete and Other Obligate Intracellular Bacterial Diseases |
| 07/28/2011 | US20110184022 Organic Compounds |
| 07/28/2011 | US20110184019 Long chain N-Alkyl compounds and oxa-derivatives thereof |
| 07/28/2011 | US20110184015 Novel derivatives of pyrroloindole which are inhibitors of hsp90, compositions containing same, and use thereof |
| 07/28/2011 | US20110184003 Compounds and methods for the treatment of viral infection |
| 07/28/2011 | US20110183977 Benzene, pyridine, and pyridazine derivatives |
| 07/28/2011 | US20110183971 3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 07/28/2011 | US20110183969 Antifungal combination therapy |
| 07/28/2011 | US20110183968 Antifungal compounds containing benzothiazinone, benzoxazinone or benzoxazolinone and process thereof |
| 07/28/2011 | US20110183961 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 07/28/2011 | US20110183940 Chemical compounds |
| 07/28/2011 | US20110183932 Three-component bone cement |
| 07/28/2011 | US20110183930 Water soluble and activable phenolics derivatives with dermocosmetic and therapeutic applications and process for preparing said derivatives |
| 07/28/2011 | US20110183924 Methods and systems for annotating biomolecular sequences |
| 07/28/2011 | US20110183923 Peptide antagonists of zonulin and methods for use of the same |
| 07/28/2011 | US20110183895 Polyheterocyclic compounds highly potent as hcv inhibitors |
| 07/28/2011 | US20110183894 Antiviral activity of the protein scytovirin and methods of use |
| 07/28/2011 | US20110183893 Non-natural mic proteins |
| 07/28/2011 | US20110183892 Methods for the treatment of viral conditions |
| 07/28/2011 | US20110183891 Methods and Compositions for Inhibiting Fungal Infection and Disease |
| 07/28/2011 | US20110183889 Salicylanilide modified peptides for use as oral therapeutics |
| 07/28/2011 | US20110183888 Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases |
| 07/28/2011 | US20110183886 Melanocortin receptor ligands |
| 07/28/2011 | US20110183011 Composition and method for topical treatment of skin lesions |
| 07/28/2011 | US20110182995 Medical and dental biomaterial and method of use for the same |
| 07/28/2011 | US20110182982 Liposome treatment of viral infections |
| 07/28/2011 | US20110182981 Gonococcal vaccines |
| 07/28/2011 | US20110182976 Lipoplex-patch based dna vaccine |
| 07/28/2011 | US20110182975 Method of conferring a protective immune response to norovirus |
| 07/28/2011 | US20110182974 Multimeric multiepitope influenza vaccines |
| 07/28/2011 | US20110182970 Nitric oxide sensors and systems |
| 07/28/2011 | US20110182946 Formation of Nanostructured Particles of Poorly Water Soluble Drugs and Recovery by Mechanical Techniques |
| 07/28/2011 | US20110182942 Meningococcal multivalent native outer membrane vesicle vaccine, methods of making and use thereof |
| 07/28/2011 | US20110182941 Alphavirus and Alphavirus Replicon Particle Formulations and Methods |
| 07/28/2011 | US20110182940 Method for producing purified influenza virus antigen |
| 07/28/2011 | US20110182939 Vaccine Adjuvants |
| 07/28/2011 | US20110182937 Dendritic Cell Vaccines |